Benzinga | Dec 16, 2021 04:37AM EST

Needham Maintains Buy on Medtronic, Lowers Price Target to $131

Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $145 to $131.